Use of Intensive Medical Services for Ovarian Cancer Patients at End of Life Increases Despite Rise in Use of Hospice
As more patients choose to spend their final days and weeks in hospice care rather than a hospital, the hope is the use of intensive and costly hospital services would decline. A new study by Dana-Farber Cancer Institute researchers shows for one...
15-Oct-2014 5:00 PM EDT
Side Effects of Cancer Prevention Surgery Can Be Helped with a Single-Day Education Program, Study Finds
More women are having ovary-removing surgery as a cancer prevention measure, but many are often unaware of sexual or psychological side effects of the procedure. A new study by researchers at Dana-Farber Cancer Institute shows a half-day educational...
10-Oct-2014 11:05 AM EDT
Scientists at Dana-Farber Cancer Institute, the Massachusetts Institute of Technology, and other institutions have discovered a sign of the early development of pancreatic cancer – an upsurge in certain amino acids that occurs before the disease...
25-Sep-2014 12:00 PM EDT
Led by Dana-Farber scientists, a large DNA analysis of people with and without pancreatic cancer has identified several new genetic markers that signal increased risk of developing the highly lethal disease.
1-Aug-2014 12:00 PM EDT
Men with newly diagnosed metastatic, hormone-sensitive prostate cancer lived more than a year longer when they received a chemotherapy drug as initial treatment instead of waiting to for the disease to become resistant to hormone-blockers, report...
1-Jun-2014 7:30 AM EDT
Clinical Trial Analysis Suggests Drug Combination May Be Highly Effective in Recurrent Ovarian Cancer
Significant improvement with the use of a combination drug therapy for recurrent ovarian cancer was reported at the annual meeting of the American Society of Clinical Oncology (ASCO) meeting in Chicago.
31-May-2014 4:00 PM EDT
Dana-Farber researchers have identified antibodies against the deadly Middle East Respiratory Syndrome that could lead to prevention/treatment for the virus with a 40% mortality rate
25-Apr-2014 4:00 PM EDT
In 2004, a team of Dana-Farber doctors discovered a gene mutation that could treated by a drug on the market for something else. This discovery transformed the way lung cancer is treated and began an era of precision medicine for lung cancer.
23-Apr-2014 12:40 PM EDT
With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST
11-Nov-2013 5:00 PM EST
National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support
17-Sep-2013 3:00 PM EDT
The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT
24-May-2013 3:00 PM EDT
Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT
The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT